Retrospective Study
Copyright ©The Author(s) 2019.
World J Gastroenterol. Mar 7, 2019; 25(9): 1100-1115
Published online Mar 7, 2019. doi: 10.3748/wjg.v25.i9.1100
Table 3 Average confidence scores among three protocols for assessment of small bowel obstruction (n = 106)
Assessment parameterProtocol 1
Protocol 2
Protocol 3
P-value
Reader 1Reader 2P-valueReader 1Reader 2P-valueReader 1Reader 2P-value
Presence or absence of SBO
Presence4.8 ± 0.54.7 ± 0.60.0704.8 ± 0.44.9 ± 0.30.1034.9 ± 0.44.8 ± 0.40.1840.110
Absence4.6 ± 0.74.8 ± 0.60.2704.9 ± 0.34.8 ± 0.40.1644.7 ± 0.54.9 ± 0.30.1880.341
Severity of obstruction
No4.6 ± 0.74.8 ± 0.60.2704.9 ± 0.34.8 ± 0.40.1644.7 ± 0.54.9 ± 0.30.1880.341
Mild4.4 ± 0.74.5 ± 0.70.1624.8 ± 0.54.7 ± 0.50.4284.7 ± 0.64.6 ± 0.60.6660.753
Moderate4.8 ± 0.44.7 ± 0.40.3234.8 ± 0.44.8 ± 0.40.7104.7 ± 0.64.8 ± 0.40.1330.418
Severe4.9 ± 0.44.8 ± 0.40.3264.9 ± 0.44.9 ± 0.41.0004.9 ± 0.34.9 ± 0.40.6630.872
Obstruction site
Proximal4.4 ± 0.74.4 ± 0.51.0004.8 ± 0.44.9 ± 0.30.5944.7 ± 0.54.8 ± 0.40.6810.323
Middle4.2 ± 0.94.3 ± 0.80.0544.6 ± 0.54.7 ± 0.50.0584.4 ± 0.74.6 ± 0.60.7100.004b
Distal4.4 ± 1.04.5 ± 0.90.0834.7 ± 0.54.7 ± 0.50.5704.6 ± 0.64.6 ± 0.60.6600.221
Cause
Adhesions3.6 ± 0.83.7 ± 0.80.0834.7 ± 0.54.8 ± 0.40.4284.5 ± 0.64.6 ± 0.60.1630.001b
Neoplasms4.1 ± 0.74.2 ± 0.60.3414.9 ± 0.34.8 ± 0.40.5884.7 ± 0.54.6 ± 0.50.5880.001b
Intussusception
Neoplasms4.1 ± 1.14.2 ± 1.00.5944.9 ± 0.34.8 ± 0.40.5944.7 ± 0.54.6 ± 0.50.5940.019a
Nonneoplasms4.2 ± 0.84.0 ± 0.70.3744.8 ± 0.44.8 ± 0.41.0004.6 ± 0.54.8 ± 0.40.3740.029a
Volvulus4.4 ± 0.74.5 ± 0.80.3515.0 ± 0.04.9 ± 0.40.3514.6 ± 0.54.8 ± 0.50.5980.041a
Hernias
Internal hernias3.3 ± 1.43.5 ± 1.00.6114.7 ± 0.54.8 ± 0.40.6114.3 ± 0.84.5 ± 0.50.6950.002b
External hernias4.7 ± 0.54.6 ± 0.70.3474.9 ± 0.35.0 ± 0.00.3474.9 ± 0.34.9 ± 0.31.0000.054
Bezoars/stones4.6 ± 0.54.7 ± 0.50.3565.0 ± 0.04.9 ± 0.40.3564.9 ± 0.44.7 ± 0.50.3560.492
Vascular lesions3.2 ± 1.33.3 ± 1.10.5944.7 ± 0.54.6 ± 0.50.5944.4 ± 0.54.3 ± 0.50.6810.001b
Inflammatory lesions3.9 ± 1.34.1 ± 1.10.3564.7 ± 0.54.4 ± 0.50.1724.3 ± 1.04.4 ± 0.50.6040.581
Findings of secondary bowel ischemia
Increased bowel wall attenuation4.4 ± 0.54.5 ± 0.50.5394.7 ± 0.54.7 ± 0.51.0004.7 ± 0.54.6 ± 0.50.6640.819
Decreased bowel wall enhancement4.5 ± 0.54.4 ± 0.50.5724.6 ± 0.54.7 ± 0.50.5364.6 ± 0.54.7 ± 0.50.7210.282
Vascular embolus/thrombosis4.0 ± 0.94.1 ± 1.00.5984.9 ± 0.44.8 ± 0.50.5984.6 ± 0.54.5 ± 0.50.5980.010a
Vascular stenosis/occlusion3.8 ± 0.83.9 ± 0.90.5034.8 ± 0.44.7 ± 0.50.2654.4 ± 0.54.5 ± 0.60.5740.001b
Pneumatosis/portomesenteric gas4.1 ± 0.34.3 ± 0.70.4474.4 ± 0.54.7 ± 0.40.0814.6 ± 0.54.7 ± 0.50.6810.814
Bowel wall thickening4.5 ± 0.54.6 ± 0.50.3214.6 ± 0.54.7 ± 0.50.1094.6 ± 0.54.7 ± 0.50.2540.059
Increased bowel wall enhancement4.6 ± 0.54.8 ± 0.40.2314.7 ± 0.54.8 ± 0.40.1614.8 ± 0.44.7 ± 0.50.5360.441
Mesenteric haziness/fluid4.3 ± 0.64.3 ± 0.60.5714.7 ± 0.54.8 ± 0.40.2924.6 ± 0.54.7 ± 0.50.5710.003b
Mesenteric vascular engorgement4.2 ± 0.64.1 ± 0.60.7484.8 ± 0.44.9 ± 0.40.4944.7 ± 0.54.8 ± 0.40.7160.001b
Small-bowel feces sign4.4 ± 0.54.6 ± 0.60.3294.7 ± 0.54.6 ± 0.50.5764.5 ± 0.54.6 ± 0.60.4280.748
Ascites4.7 ± 0.54.6 ± 0.50.5834.9 ± 0.44.8 ± 0.40.6714.8 ± 0.44.7 ± 0.50.5830.848